APA (7th ed.) Citation

ZC, K., S, V., M, B., O, R., A, N., P, D., . . . C, B. (2026). Toward the development of an innovative pharmacological compound employing peptides for EGFR-mediated drug delivery in anaplastic thyroid carcinoma. Biochemical pharmacology, 243(Pt 1), 117448. https://doi.org/10.1016/j.bcp.2025.117448

Chicago Style (17th ed.) Citation

ZC, Kahvecioglu, et al. "Toward the Development of an Innovative Pharmacological Compound Employing Peptides for EGFR-mediated Drug Delivery in Anaplastic Thyroid Carcinoma." Biochemical Pharmacology 243, no. Pt 1 (2026): 117448. https://doi.org/10.1016/j.bcp.2025.117448.

MLA (9th ed.) Citation

ZC, Kahvecioglu, et al. "Toward the Development of an Innovative Pharmacological Compound Employing Peptides for EGFR-mediated Drug Delivery in Anaplastic Thyroid Carcinoma." Biochemical Pharmacology, vol. 243, no. Pt 1, 2026, p. 117448, https://doi.org/10.1016/j.bcp.2025.117448.